Physician profile
Scott A Hyman
NPI 1952332280
$732.06
in general payments reported to CMS, 2019-2025
16 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.45 · 2020: $111 · 2021: $34.88 · 2022: $81.26 · 2023: $179 · 2024: $112 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $132.60 | 2019-2025 | Grafix Pl, Collagenase Santyl |
| Convatec INC. | $83.59 | 2023 | |
| Paratek Pharmaceuticals, INC. | $65.54 | 2022-2024 | Nuzyra |
| Organogenesis INC. | $63.98 | 2025 | Cygnus Dual, Apligraf |
| Abbott Laboratories | $55.91 | 2019-2023 | Axium, Octrode |
| Boston Scientific Corporation | $53.12 | 2020-2021 | |
| Treace Medical Concepts, INC. | $44.67 | 2025 | |
| Kci USA, INC. | $36.35 | 2020-2023 | Activ.A.C., Promogran Prisma |
| Medtronic, INC. | $36.28 | 2024 | Vanta Adaptivestim |
| Bioventus LLC | $35.91 | 2020-2022 | |
| Orthofix Medical, INC. | $33.57 | 2020 | |
| Kerecis Limited | $22.94 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $22.79 | 2024 | |
| Osiris Therapeutics INC. | $18.65 | 2019 | |
| Averitas Pharma INC. | $14.25 | 2023 | Qutenza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.